144 related articles for article (PubMed ID: 9708191)
1. Multifaceted inhibition of anti-tumour immune mechanisms by soluble tumour necrosis factor receptor type I.
Selinsky CL; Boroughs KL; Halsey WA; Howell MD
Immunology; 1998 May; 94(1):88-93. PubMed ID: 9708191
[TBL] [Abstract][Full Text] [Related]
2. Soluble tumor necrosis factor receptor type I enhances tumor development and persistence in vivo.
Selinsky CL; Howell MD
Cell Immunol; 2000 Mar; 200(2):81-7. PubMed ID: 10753499
[TBL] [Abstract][Full Text] [Related]
3. Increased proliferation of endothelial cells with overexpression of soluble TNF-alpha receptor I gene.
Sugano M; Tsuchida K; Tomita H; Makino N
Atherosclerosis; 2002 May; 162(1):77-84. PubMed ID: 11947900
[TBL] [Abstract][Full Text] [Related]
4. Compromised anti-tumor responses in tumor necrosis factor-alpha knockout mice.
Baxevanis CN; Voutsas IF; Tsitsilonis OE; Tsiatas ML; Gritzapis AD; Papamichail M
Eur J Immunol; 2000 Jul; 30(7):1957-66. PubMed ID: 10940885
[TBL] [Abstract][Full Text] [Related]
5. Soluble tumor necrosis factor-alpha (TNF-alpha) receptors in human colostrum and milk bind to TNF-alpha and neutralize TNF-alpha bioactivity.
Buescher ES; McWilliams-Koeppen P
Pediatr Res; 1998 Jul; 44(1):37-42. PubMed ID: 9667368
[TBL] [Abstract][Full Text] [Related]
6. Cytotoxicity in L929 murine fibrosarcoma cells after triggering of transfected human p75 tumour necrosis factor (TNF) receptor is mediated by endogenous murine TNF.
Vercammen D; Vandenabeele P; Declercq W; Van de Craen M; Grooten J; Fiers W
Cytokine; 1995 Jul; 7(5):463-70. PubMed ID: 7578985
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-12 up-regulates perforin- and Fas-mediated lymphokine-activated killer activity by intestinal intraepithelial lymphocytes.
Ebert EC
Clin Exp Immunol; 2004 Nov; 138(2):259-65. PubMed ID: 15498035
[TBL] [Abstract][Full Text] [Related]
8. Soluble tumor necrosis factor receptor I (sTNFRI) as a prognostic factor in melanoma patients in Slovene population.
Galvani V; Pretnar Hartman K; Rupreht RR; Novaković S; Stabuc B; Ocvirk J; Menart V; Gaberc Porekar V; Stalc A; Rozman P; Curin Serbec V
Pflugers Arch; 2000; 440(5 Suppl):R61-3. PubMed ID: 11005614
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of in vitro prostaglandin E2 production by mouse fibrosarcoma cells after co-culture with various anti-tumour effector cells.
Okada F; Hosokawa M; Hasegawa J; Kuramitsu Y; Nakai K; Yuan L; Lao H; Kobayashi H; Takeichi N
Br J Cancer; 1994 Aug; 70(2):233-8. PubMed ID: 8054271
[TBL] [Abstract][Full Text] [Related]
10. [Construction of adenoviral vector encoding soluble human sTNFRI-IgGFc cDNA and its expression in human airway smooth muscle cells (HASMCs)].
Su J; You C; Cai S; Ma L; Wang X; Wen Q; Luo W; Huang Y
Sheng Wu Gong Cheng Xue Bao; 2008 May; 24(5):774-9. PubMed ID: 18724696
[TBL] [Abstract][Full Text] [Related]
11. Preconditioning up-regulates the soluble TNF receptor I response to endotoxin.
Wang M; Meng X; Tsai B; Wang JF; Turrentine M; Brown JW; Meldrum DR
J Surg Res; 2004 Sep; 121(1):20-4. PubMed ID: 15313370
[TBL] [Abstract][Full Text] [Related]
12. Receptors and lytic mediators regulating anti-tumor activity by the leukemic killer T cell line TALL-104.
Brando C; Mukhopadhyay S; Kovacs E; Medina R; Patel P; Catina TL; Campbell KS; Santoli D
J Leukoc Biol; 2005 Aug; 78(2):359-71. PubMed ID: 15937142
[TBL] [Abstract][Full Text] [Related]
13. Resistance of different tumor cells to lysis by lymphokine activated killer cells can be mediated by distinct mechanisms.
Bean P; Mazumder A
Immunobiology; 1992 Jun; 185(1):63-77. PubMed ID: 1398742
[TBL] [Abstract][Full Text] [Related]
14. Plasma concentrations of soluble tumor necrosis factor receptor I and tumor necrosis factor during cardiopulmonary bypass.
Marano CW; Garulacan LA; Laughlin KV; Igidbashian L; Trace C; Goldman SM; Sutter FP; Reichard GA; Mullin JM
Ann Thorac Surg; 2000 Oct; 70(4):1313-8. PubMed ID: 11081891
[TBL] [Abstract][Full Text] [Related]
15. [Bioassay of the soluble human tumor necrosis factor receptor I recombinant plasmid expression in vitro].
Xu CR; Zhang JC; Zhao CJ; Zhang YH
Zhonghua Kou Qiang Yi Xue Za Zhi; 2004 May; 39(3):185-8. PubMed ID: 15196381
[TBL] [Abstract][Full Text] [Related]
16. Perforin, Fas ligand, and tumor necrosis factor are the major cytotoxic molecules used by lymphokine-activated killer cells.
Lee RK; Spielman J; Zhao DY; Olsen KJ; Podack ER
J Immunol; 1996 Sep; 157(5):1919-25. PubMed ID: 8757310
[TBL] [Abstract][Full Text] [Related]
17. Triggered human mucosal T cells release tumour necrosis factor-alpha and interferon-gamma which kill human colonic epithelial cells.
Deem RL; Shanahan F; Targan SR
Clin Exp Immunol; 1991 Jan; 83(1):79-84. PubMed ID: 1899066
[TBL] [Abstract][Full Text] [Related]
18. Development of a baculovirus expression system for soluble porcine tumor necrosis factor receptor type I and soluble porcine tumor necrosis factor receptor type I-IgG fusion protein.
Mwangi SM; Stabel TJ; Kehrli ME
Vet Immunol Immunopathol; 2002 Jul; 86(3-4):251-4. PubMed ID: 12007891
[TBL] [Abstract][Full Text] [Related]
19. Increase in immunogenicity and sensitivity to natural cell-mediated cytotoxicity following in vitro exposure of MCA105 tumor cells to ultraviolet radiation.
Begovic M; Herberman R; Gorelik E
Cancer Res; 1991 Oct; 51(19):5153-9. PubMed ID: 1913641
[TBL] [Abstract][Full Text] [Related]
20. Reduction of arthritis and pneumonitis in motheaten mice by soluble tumor necrosis factor receptor.
Su X; Zhou T; Yang P; Edwards CK; Mountz JD
Arthritis Rheum; 1998 Jan; 41(1):139-49. PubMed ID: 9433879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
